Epigenetics in bipolar disorder: a critical review of the literature
The DOI matches its Crossref record; 117 of the 130 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Bipolar disorder (BD) is a chronic, disabling disease characterised by alternate mood episodes, switching through depressive and manic/hypomanic phases. Mood stabilizers, in particular lithium salts, constitute the cornerstone of the treatment in the acute phase as well as for the prevention of recurrences. The pathophysiology of BD and the mechanisms of action of mood stabilizers remain largely unknown but several pieces of evidence point to gene x environment interactions. Epigenetics, defined as the regulation of gene expression without genetic changes, could be the molecular substrate of these interactions. In this literature review, we summarize the main epigenetic findings associated with BD and response to mood stabilizers. METHODS: We searched PubMed, and Embase databases and classified the articles depending on the epigenetic mechanisms (DNA methylation, histone modifications and non-coding RNAs). RESULTS: We present the different epigenetic modifications associated with BD or with mood-stabilizers. The major reported mechanisms were DNA methylation, histone methylation and acetylation, and non-coding RNAs. Overall, the assessments are poorly harmonized and the results are more limited than in other psychiatric disorders (e.g. schizophrenia). However, the nature of BD and its treatment offer excellent opportunities for epigenetic research: clear impact of environmental factors, clinical variation between manic or depressive episodes resulting in possible identification of state and traits biomarkers, documented impact of mood-stabilizers on the epigenome. CONCLUSION: Epigenetic is a growing and promising field in BD that may shed light on its pathophysiology or be useful as biomarkers of response to mood-stabilizer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · cited 1×
“Another limit of these approaches is that variants in miRNA were not significantly associated with BD in large cohorts, as this was the case in the latest schizophrenia GWAS that confirmed miR137 role (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014).”
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 1×
“Chemical modifications in DNA and histones determine the chromatin conformation and, thereby, the accessibility to transcription factors on which gene expression depends (Bannister and Kouzarides, 2011).”
BackgroundRegulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
Exosomes: biogenesis, biologic function and clinical potential
Zhang, Y., Liu, Y., Liu, H., & Tang, W. H. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0282-2 · Cited by 2,119
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852 · cited 1×
“Mood-stabilizers are the treatment of choice, both in the acute phase and to prevent relapses, but antipsychotics and antidepressants can be added throughout as adjunctive therapy (National Collaborating Centre for Mental Health (UK), 2014; Goodwin et al., 2016; Yatham et al., 2018).”
BackgroundGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Gandal, M. J., Zhang, P., Hadjimichael, E., Walker, R. L., Chen, C., Liu, S., Won, H., van Bakel, H., Varghese, M., Wang, Y., et al. (2018) · Science · doi:10.1126/science.aat8127 · Cited by 1,247
Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.471 · Cited by 1,177
Cited by
Ortega, M. A., Álvarez-Mon, M. Á., Montero, C. G., Fraile‐Μartinez, O., Monserrat, J., Martinez-Rozas, L., Rodríguez–Jiménez, R., Álvarez‐Mon, M., & Lahera, G. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01964-w · Cited by 150
“…argue that because of the nature of BD and its therapy, the fi eld of epigenetics can be critical for understanding the clinical course of this complex disorder, aiding to de fi ne the role of environmental factors, and the possible identi fi cation of promising state and traits biomarkers [25].”
BackgroundLiu, T., Du, D., Zhao, R., Xie, Q., & Dong, Z. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127440 · Cited by 25
Hesam-Shariati, S., Overs, B. J., Roberts, G. M. P., Toma, C., Watkeys, O. J., Green, M. J., Pierce, K. D., Edenberg, H. J., Wilcox, H. C., Stapp, E. K., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02079-6 · Cited by 23
“To date, there are no large-scale epigenome-wide studies in BD [34], although several candidate-gene epigenetic studies [35, 36] and pharmaco-epigenomic studies of antipsychotic medicines [37] have been performed.”
BackgroundNon-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
Machado-Vieira, R., Courtes, A. C., Zarate, C., Henter, I., & Manji, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1228455 · Cited by 18
“It should be noted that although direct evidence for epigenetic dysfunction in BD is still limited, advances in epigenomic profiling technologies offer an exciting opportunity to investigate molecular modifications to DNA and histones (Legrand et al., 2021).”
BackgroundMokhtari, A., Porte, B., Belzeaux-R, R., Étain, B., Ibrahim, E. C., Marie-Claire, C., Lutz, P.-É., & Delahaye‐Duriez, A. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110520 · Cited by 20
Metadata
- Authors
- Legrand, A., Iftimovici, A., Khayachi, A., & Chaumette, B.
- Affiliations
- Inserm (FR)
- Montreal Neurological Institute and Hospital (CA)
- Corresponding author
- Chaumette, Boris
- Venue
- Psychiatric Genetics
- Published
- 2020-12-07
- Volume
- 31
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0955-8829 (ISSN-L)
- OpenAlex
- W3111867040
- Cited by
- 48
- References
- 130
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 10 · 2022: 8 · 2021: 3
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-18-PERM-0008)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar disorder, epigenetics, gene-environment interaction, DNA methylation, histone modifications, non-coding RNA, mood stabilizers, lithium, treatment response biomarkers, pathophysiology
- MeSH terms
- Adult Survivors of Child Adverse Events, Affect, Bipolar Disorder, Female, Humans, Male, Organ Specificity, Psychotropic Drugs, Epidemiologic Research Design, DNA Methylation, RNA, Untranslated, Histone Code, Epigenesis, Genetic, Genetic Association Studies, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetics in bipolar disorder: a critical review of the literature. https://app.cochat.ai/papers/10.1097/ypg.0000000000000267
- The paper
- Legrand, A., Iftimovici, A., Khayachi, A., & Chaumette, B. (2021). Epigenetics in bipolar disorder: a critical review of the literature. Psychiatric Genetics. https://doi.org/10.1097/ypg.0000000000000267
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.